Cascadian Therapeutics (CASC) –
-
BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program
-
BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program
-
BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
-
Form SC 13D/A Cascadian Therapeutics, Filed by: Growth Equity Opportunities IV, LLC
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Walker Luke Nathaniel
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: James Steven P
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: LOVE TED W
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Fyfe Gwen A.
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Viswanathan Ravi
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Sonsini Peter W.
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: SANDELL SCOTT D
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Sakoda Jon
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: MAKOWER JOSHUA
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Azelby Robert
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: MOTT DAVID M
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: PETERSON SCOTT ROBERT
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Florence Anthony A. Jr.
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: SPIEGELMAN DANIEL K
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Myers Scott Dunseth
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: BASKETT FOREST
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: BARRIS PETER J
-
Form 4 Growth Equity Opportunit For: Mar 09 Filed by: Cascadian Therapeutics, Inc.
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: Christianson Gary
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: HENNEY CHRISTOPHER S
-
Form 4 Cascadian Therapeutics, For: Mar 09 Filed by: EASTLAND JULIA MARIE
-
Form 8-K Cascadian Therapeutics, For: Mar 09
-
Form POS AM Cascadian Therapeutics,
-
Form POS462B Cascadian Therapeutics,
-
Form POS AM Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form POS AM Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form POS AM Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Form S-8 POS Cascadian Therapeutics,
-
Seattle Genetics (SGEN) Completes Acquisition of Cascadian Therapeutics (CASC)
-
Form 25-NSE Cascadian Therapeutics, Filed by: The Nasdaq Stock Market LLC
-
Form SC 14D9/A Cascadian Therapeutics, Filed by: Cascadian Therapeutics, Inc.
-
Form SC TO-T/A Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA
-
Seattle Genetics Completes Tender Offer for All Shares of Cascadian Therapeutics
-
Form 10-K Cascadian Therapeutics, For: Dec 31
-
Form SC 13D/A Cascadian Therapeutics, Filed by: Growth Equity Opportunities IV, LLC
-
Form SC 14D9/A Cascadian Therapeutics, Filed by: Cascadian Therapeutics, Inc.
-
Form 4 Cascadian Therapeutics, For: Feb 20 Filed by: Sakoda Jon
-
Form 4 Cascadian Therapeutics, For: Feb 20 Filed by: Viswanathan Ravi
Back to CASC Stock Lookup